UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Davis Capital Management

Davis Capital Management increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,090 shares of the healthcare conglomerate’s stock after acquiring an additional 101 shares during the period. Davis Capital Management’s holdings in UnitedHealth Group were worth $637,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of UNH. Signature Resources Capital Management LLC boosted its holdings in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares in the last quarter. Saxony Capital Management LLC grew its position in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after acquiring an additional 18 shares during the period. GoalVest Advisory LLC boosted its position in UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 18 shares in the last quarter. Fiduciary Group LLC increased its position in shares of UnitedHealth Group by 0.5% in the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after buying an additional 18 shares in the last quarter. Finally, Continuum Advisory LLC lifted its position in shares of UnitedHealth Group by 0.6% during the 2nd quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock valued at $1,737,000 after buying an additional 19 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.5 %

Shares of UNH opened at $592.30 on Thursday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market cap of $546.94 billion, a P/E ratio of 36.20, a price-to-earnings-growth ratio of 1.62 and a beta of 0.58. The company’s 50-day moving average price is $581.15 and its 200 day moving average price is $526.18. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.14 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on UNH shares. Robert W. Baird upped their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Barclays increased their target price on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Wells Fargo & Company boosted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their target price for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, Truist Financial boosted their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.